Disabling ErbB Receptors with Rationally Designed Exocyclic Mimetics of Antibodies: Structure−Function Analysis-Reference-Cited by-同舟云学术

Disabling ErbB Receptors with Rationally Designed Exocyclic Mimetics of Antibodies: Structure−Function Analysis

Published:2001-07-10 Issue:16 Volume:44 Page:2565-2574
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Berezov Alan¹,Zhang Hong-Tao¹,Greene Mark I.¹,Murali Ramachandran¹

Affiliation:

1. Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, 36th and Hamilton Walk, Philadelphia, Pennsylvania 19104

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm000527m

Reference73 articles.

1. HER‐2/ neu Signal Transduction in Human Breast and Ovarian Cancer

2. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High sensitivity saliva-based biosensor in detection of breast cancer biomarkers: HER2 and CA15-3;Journal of Vacuum Science & Technology B;2024-02-13

2. Surface plasmon resonance as a fascinating approach in target-based drug discovery and development;TrAC Trends in Analytical Chemistry;2024-02

3. Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics;Nanomaterials;2023-09-01

4. Platinum anticancer drugs: Targeting and delivery;Comprehensive Inorganic Chemistry III;2023

5. Development of an SPR-based binding assay for characterization of anti-CD20 antibodies to CD20 expressed on extracellular vesicles;Analytical Biochemistry;2022-06